TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharma Production i Stockholm AB
Closing information (x1000 DKK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
8,127
|
7,551
|
8,495 |
| Financial expenses |
0
|
0
|
3 |
| Earnings before taxes |
3,084
|
2,948
|
3,888 |
| EBITDA |
3,033
|
2,965
|
3,904 |
| Total assets |
4,229
|
2,696
|
3,108 |
| Current assets |
4,158
|
2,606
|
3,046 |
| Current liabilities |
2,292
|
548
|
705 |
| Equity capital |
1,937
|
2,148
|
2,402 |
| - share capital |
66
|
63
|
70 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
45.8%
|
79.7%
|
77.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
37.9%
|
39.0%
|
45.8% |
| Return on assets (ROA) |
72.9%
|
109.3%
|
125.2% |
| Current ratio |
181.4%
|
475.5%
|
432.1% |
| Return on equity (ROE) |
159.2%
|
137.2%
|
161.9% |
| Change turnover |
277
|
-150
|
-104 |
| Change turnover % |
4%
|
-2%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.